TARDBP and amyotrophic lateral sclerosis: Our orthogonal approach to drug discovery has led to a novel target and mechanism with remarkable efficacy at rescue of both TDP-43 mislocalization and stress-induced aggregation, the biochemical hallmarks of ALS, with improvement of symptoms observed in a diversity of transgenic animal models for ALS.